CLINICAL_TRIALS
trial_result
· 2016-07-27
Clinical Trial Update: A Study of Prasugrel in Pediatric Participants With Sickle Cell Disease (SCD) [Phase 3]
Summary
Phase 3 clinical trial evaluating prasugrel in pediatric patients with sickle cell disease was terminated; results posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Sickle Cell Disease | Phase 3 | Status: TERMINATED | Results posted: 2016-07-27